Adial Pharmaceuticals (ADIL) Intangibles (2017 - 2026)
Adial Pharmaceuticals' Intangibles came in at $3,000 for Q2 2026, down 2.2% from $3,066 a year earlier but up 13.5% from the prior quarter.
Powered by 
Analysis
Adial Pharmaceuticals (ADIL) Intangibles (2017 - 2026) Analysis & Trends
Going back to Q4 2017, Adial Pharmaceuticals' Intangibles data covers 34 quarters.
- Intangibles has declined in each of the last eight years, with a five-year compound annual growth rate of -11.8% (FY2020 to FY2025).
- Going back by year, Intangibles was $3,348 in FY2024 (-14.4%), $3,913 in FY2023 (-12.6%), $4,477 in FY2022 (-11.2%) and $5,041 in FY2021 (-10.1%).
- The five-year range for quarterly Intangibles is $2,643 (Q1 2026) to $5,183 (Q3 2021).
- Year-over-year, Intangibles has declined for 29 consecutive quarters, with an average decline of 13.2% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 2.2% (Q2 2026) and 17.6% (Q1 2026) over the last five years.
- Business Quant data shows ADIL's Intangibles at $2,643 (Q1 2026), $3,000 (Q4 2025) and $2,925 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Adial Pharmaceuticals | 18.53 Mn | 18.53 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 2,643.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 2,925.00 |
| Jun 30, 2025 | 3,066.00 |
| Mar 31, 2025 | 3,207.00 |
| Dec 31, 2024 | 3,348.00 |
| Sep 30, 2024 | 3,489.00 |
| Jun 30, 2024 | 3,631.00 |
| Mar 31, 2024 | 3,772.00 |
| Dec 31, 2023 | 3,913.00 |
| Sep 30, 2023 | 4,054.00 |
| Jun 30, 2023 | 4,195.00 |
| Mar 31, 2023 | 4,336.00 |
| Dec 31, 2022 | 4,477.00 |
| Sep 30, 2022 | 4,618.00 |
| Jun 30, 2022 | 4,759.00 |
| Mar 31, 2022 | 4,900.00 |
| Dec 31, 2021 | 5,041.00 |
| Sep 30, 2021 | 5,183.00 |
API Access
Adial Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ADIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ADIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ADIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();